Caribou Biosciences (CRBU) Non Operating Income (2020 - 2026)
Caribou Biosciences' Non Operating Income was $1.06 million in Q2 2026, compared with -$6.52 million a year earlier and down 11.5% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Non Operating Income (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Caribou Biosciences' Non Operating Income was $5.52 million through Jun 30, 2026, up 65.6% year-over-year; for FY2025, it was -$331,000.
- In earlier years, Non Operating Income was $17.5 million in FY2024 (+23.4%), $14.18 million in FY2023 (+101.2%), $7.05 million in FY2022 and $377,000 in FY2021.
- Quarterly Non Operating Income has moved between -$6.52 million (Q2 2025) and $5.8 million (Q2 2024) over five years.
- Compared with a year earlier, Non Operating Income was higher in 1 of the last six quarters, with an average decline of 36.5%.
- The best year-over-year quarter for Non Operating Income over five years was Q2 2023 (growth of 93.1%); the worst was Q1 2026 (a decline of 59.1%).
- Per Business Quant data, CRBU's Non Operating Income in the three quarters before Q2 2026 was $1.2 million (Q1 2026), $1.42 million (Q4 2025) and $1.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.70 Bn | 1,138.29 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 647.50 Bn | 567.36 Bn | 17.30 Bn | - |
| 3 | AbbVie | 504.26 Bn | 477.37 Bn | 12.70 Bn | - |
| 4 | Merck | 368.38 Bn | 322.75 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 303.14 Bn | 267.13 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.24 Bn | 241.93 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.50 Bn | 197.90 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 173.14 Bn | 119.78 Bn | 10.94 Bn | - |
| 10 | Caribou Biosciences | 55.50 Mn | -461.04 Mn | - | 1.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | -6.52 Mn |
| Mar 31, 2025 | 2.92 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 5.80 Mn |
| Mar 31, 2024 | 4.77 Mn |
| Dec 31, 2023 | 3.13 Mn |
| Sep 30, 2023 | 4.63 Mn |
| Jun 30, 2023 | 3.35 Mn |
| Mar 31, 2023 | 3.07 Mn |
| Dec 31, 2022 | 3.66 Mn |
| Sep 30, 2022 | -110,000.00 |
| Jun 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 2.25 Mn |
| Sep 30, 2021 | -2.36 Mn |
API Access
Caribou Biosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();